Science & Innovation

Quarterly Update Q3 2021

purple down arrow icon
a female scientist smiling at the camera in a lab

Tobacco Harm
Reduction through world-class science

Tobacco Harm
Reduction through world-class science

Our purpose is to build A Better Tomorrow™ by reducing the health impact of our business. It’s why we invest almost £350 million a year to find innovative new ways to contribute to Tobacco Harm Reduction, and aim to have 50 million consumers of our non-combustible products by 2030.

Find out more

What’s new in Tobacco Heating Products?

Tobacco Heating Products (THP) are a relatively new alternative nicotine product that are becoming an increasingly important option for adult smokers, and have the potential to make a significant contribution to Tobacco Harm Reduction.

Find out more
a tobacco heating product on a desk in front of a laptop
a female scientist using a pipet and a test tube

What’s new in Vapour?

It is recognised by many public health bodies that cigarette smokers who switch completely to vaping are likely to reduce their risk of developing smoking-related diseases and premature death.

Find out more

What’s new in Modern Oral?

Modern Oral Products provide a convenient way to enjoy nicotine and now new evidence, recently published in the Drug and Chemical Toxicology journal, suggests BAT’s nicotine pouches have a toxicant profile that is comparable to nicotine replacement therapy products (NRTs)1.

Find out more
a female scientist inspecting something she's holding
text that reads click here to find out more
a scientist looking into a microscope

In the news: Eurobarometer Report

A new report into the attitude of Europeans towards tobacco and electronic cigarettes suggests that there is a real opportunity across Europe to help people make more informed lifestyle choices1.

Find out more
text that reads click here to find out more

In the news:
Public Health England report

People need access to clear information about vaping and smoking. If they don't know the risks, they can't make informed decisions. Which is why a recent report from Public Health England (PHE) is important to better understand the levels of public awareness of vaping and how best to inform people about less risky* alternatives to cigarettes.

Find out more
a close up shot of some beakers in a lab

Forward-looking
statements

This is a report by British American Tobacco p.l.c.; associate companies are excluded.

References to ‘British American Tobacco’, ‘BAT’, ‘we’, ‘us’ and ‘our’ when denoting opinion refer to British American Tobacco p.l.c. (the Company, and together with its subsidiaries, the ‘Group’), and when denoting tobacco business activity refer to Group operating companies, collectively or individually as the case may be.

This report contains certain forward-looking statements, including “forward-looking” statements made within the meaning of the US Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use of words or phrases such as “believe,” “anticipate,” “could,” “may,” “would,” “should,” “intend,” “plan,” “potential,” “predict,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “outlook”, “target” and similar expressions. These include statements regarding our intentions, beliefs or current expectations reflecting knowledge and information available at the time of preparation, and concerning our results of operations, financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which the Company operates, including the projected future financial and operating impacts of the COVID-19 pandemic.

All such forward-looking statements involve estimates and assumptions that are subject to risks, uncertainties and other factors. It is believed that the expectations reflected in this report are reasonable but they may be affected by a wide range of variables that could cause actual results to differ materially from those currently anticipated.

Among the key factors that could cause actual results to differ materially from those projected in the forward looking statements are uncertainties related to the following: the impact of adverse domestic or international legislation and regulation; the inability to develop, commercialise and deliver the Group’s New Categories strategy; the impact of significant increases or structural changes in tobacco, nicotine and New Categories-related taxes; changes or differences in domestic or international economic or political conditions; the impact of serious injury, illness or death in the workplace; adverse decisions by domestic or international regulatory bodies; and the inability to lead the development and roll-out of BAT innovations (New Category products and combustibles), including as a result of unsuccessful research and development or a failure to develop robust scientific risk assessment frameworks.

The forward-looking statements reflect knowledge and information available at the date of preparation of these materials, and the Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on such forward-looking statements.

The material in this report is provided for the purpose of giving information about the Company to stakeholders only and is not intended for general consumers. The Company, its directors, officers, employees, agents or advisers do not accept or assume responsibility to any other person to whom this material is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed.

The material in this Report is not provided for product advertising, promotional or marketing purposes. This material does not constitute and should not be construed as constituting an offer to sell, or a solicitation of an offer to buy, any of our products. Our products are sold only in compliance with the laws of the particular jurisdictions in which they are sold.

Additional information concerning these and otherfactors can be found in BAT’s filings with the USSecurities and Exchange Commission (“SEC”), including the Annual Report on Form 20-F and Current Reports on Form 6-K, which may be obtained free of charge at the SEC’s website, http://www.sec.gov.

1/3
left arrow icon
right arrow icon